Life Science Leader Magazine Supplements

CRO Leadership Awards 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 16 of 45

Nabulsi. "That is the best way to achieve operational excel- lence. Moving forward we will look at the expertise PRA brings to the table and move forward with what we together think is best. We let them know we were not coming into this relation- ship insisting that they use the processes and procedures we had in place. We believe that will be a very positive outcome of this partnership." L tion to another. We are trying to make that message very clear." Since culture is important to the partnership, determining the culture of the candidates was important, and the site visits were a critical component of the selection process. Takeda took a close look at the employees: How they worked, how they interacted with each other, how they expressed them- selves, how they communicated with Takeda personnel, and how natural they were in those conversations. Employees were also asked about how they dealt with internal transformations and prior mergers and acquisitions. "Having that communication with employees, whether it was formal or informal, gave us a good sense of their internal culture," says Nabulsi. "They allowed us to see how they think, what is important to them, and what they value in partners. That helped us to determine what it would be like to work with them as colleagues and partners and how they work and interact. We wanted to know how they motivate their employees and how they develop their internal talent. We wanted to be sure that our people would be working in the right environment and would be motivated to work there." STILL MORE WORK TO DO Although Nabulsi is very pleased with the relationship thus far, he adds there is a lot more work to be done. Much of that centers on execution of the part- nership and taking the vision of the two companies and making it a reality. He is looking forward to seeing that execu- tion come to fruition, and is confident it will be done. "We believe this is a model other companies will want to emulate," he adds. CROs often complain that a sponsor will spend months deciding on the best partner and then proceed to tell them how to do their job. Nabulsi notes that will not be the case with this relation- ship and is a part of the execution chal- lenge. Takeda's goal from the outset was to improve operational excellence, and that entails ensuring the best prac- tices of both companies are used in its clinical trials. " We are very open to using the pro- cesses of our chosen partner," adds The Full-Service CRO Partner You Can Trust | © Copyright Altasciences 2017 • Over 25 years of clinical research excellence in early phase drug development • State-of-the-art Clinical Pharmacology Units (CPUs) in North America, including controlled ventilation smoking facilities • Extensive searchable in-house database of healthy normal and patient populations • Full array of clinical support services, including: - Project Management - Scientific and Medical Writing - Regulatory Affairs - Data Management / Biostatistics - PK and PD Analysis • Preclinical to Phase IV Bioanalytical support • Flexible, quality solutions with a focus on customer service LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2017 15

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2017